Nausea Medicine Market Research Report- Global forecast till 2023

Nausea Medicine Market Research Report- Global forecast till 2023

ID: MRFR/HC/3105-HCRR | October, 2017 | Region: Global | 110 pages | Half-Cooked Research Reports

Nausea Medicine Market Information: By Type (Antacids, Antagonists), Mode of Administration (IV, Tablets), Indication (GERD, Chemotherapy), Indication (Gastroenteritis, Gastric Ulcer), End User (Hospitals, Clinics, Pharmaceutical Companies) - Global Forecast till 2023

FIGURE 1: Global Nausea Medicine Market by Region, 2016 (%)

Nausea Medicine Market


Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation


 


Intended Audience



  • Nausea Medicine Manufacturers

  • Nausea Medicine Suppliers

  • Medical Research Laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors




Research Methodology:

Nausea Medicine Market-


Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation


Market Synopsis of the Global Nausea Medicine Market


Nausea is a state of stomach distress with an urge to vomit. Common indications of nausea are motion sickness, seasickness, medication and chemotherapy. Stomach ulcers can also cause nausea. Medications and proper dietary habits can treat nausea.


Rising prevalence of gastrointestinal diseases, such as Gastroesophageal Reflux Disease (GERD), and viral gastroenteritis, and availability of a wide range of treatment options drive the market growth. Furthermore, changing lifestyle and dietary habits also influence the market.


The global nausea medicine market is expected to grow at a CAGR of 7.2% during the forecast period.


Segments                                                                                                                                            


The global nausea medicine market is segmented on the basis of type, mode of administration, indication and end user.


On the basis of type, market is segmented into antacids, antagonists, anti-anxiety drugs, steroids, Cannabinoids and Others.


Antacids are further segmented into serotonin (5-HT3) antagonists, NK-1 antagonists and dopamine antagonists.


On the basis of mode of administration, the market is segmented into IVs, tablets and others.


On the basis of indication, the market is segmented into gastroesophageal reflux disease (GERD), viral gastroenteritis, motion sickness and seasickness, medication, chemotherapy and others.


On the basis of end user, the market is segmented into hospitals, clinics, pharmaceutical companies and others.


Regional Analysis of the Global Nausea Medicine Market                    


America is the largest market for nausea medicine owing to rising prevalence of gastrointestinal diseases such as GERD drive the market. Furthermore, according to an article published in the “The Journal of Pediatrics” the prevalence of nausea is founding to be increasing among school going children. It also stated the Functional Gastrointestinal Disorders (FGIDs) are frequently associated with nausea. Prevalence of viral gastroenteritis is found to be increasing in the U.S., especially among the pediatric population. According to the Center for Disease Control and Prevention (CDC), each year in the United States, there are nearly 19 to 21 million cases of acute gastroenteritis. Furthermore the prevalence of acute gastrointestinal diseases is found to be high in Canada.


Europe is the second largest market for nausea medicine which exhibits growth opportunities owing to the high prevalence of nausea and vomiting among pregnant women whose population is found to be increasing. Furthermore, there is an extensive demand for the diagnosis and treatment of nausea, especially among pregnant women which will influence the market growth in Europe. Additionally, prevalence of chemotherapy induced nausea is found to be increasing steadily in many parts for the Europe in the last few years. This will further increase the demand for nausea medicine in Europe.


In Asia Pacific, the market is expected grow at the fastest rate owing to changing lifestyle and increasing geriatric population fuel the market growth. Furthermore, viral gastritis and gastric ulcer are found to be prevalent among the Asian Population.  However, presence of misbranded and spurious drugs may restrain the market growth in Asia Pacific.


The Middle East & Africa also show a steady rise in the market owing to rising prevalence of chemotherapy induced nausea.


Key Players in the Global Nausea Medicine Market     


Some of the key players in this market are Merck & Co., Inc. (U.S.), Sanofi (France), TESARO, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Pfizer (U.S.), GlaxoSmithKline (U.S.), ANI Pharmaceuticals, Inc. (U.S.)

 Table of Content    

1.    Report Prologue    

2.    Market Introduction    


      2.1    Definition    

      2.2    Scope of the Study    

            2.2.1    Research Objective    

            2.2.2    Assumptions    

            2.2.3    Limitations    

3.    Research Methodology

      3.1    Introduction

      3.2    Primary Research    

      3.3    Secondary research    

      3.4    Market Size Estimation

4.    Market Dynamics

      4.1    Drivers    

      4.2    Restrains

      4.3    Opportunities    

      4.4    Challenges

      4.5    Macroeconomic Indicators

      4.6    Technology Trends & Assessment            

5.    Market Factor Analysis

      5.1    Porters Five Forces Analysis

            5.1.1    Bargaining Power of Suppliers    

            5.1.2    Bargaining Power of Buyers

            5.1.3    Threat of New Entrants    

            5.1.4    Threat of Substitutes    

            5.1.5    Intensity of Rivalry    

      5.2    Value Chain Analysis

      5.3    Investment Feasibility Analysis    

      5.4    Pricing Analysis

6.    Global Nausea Medicine Market, by Types

     6.1    Introduction

      6.2    Antacids

            6.2.1    Market Estimates & Forecast, 2017-2023

      6.3    Antagonists

            6.3.1    Market Estimates & Forecast, 2017-2023

      6.4    Anti-anxiety drugs

            6.4.1    Market Estimates & Forecast, 2017-2023

      6.5    Steroids

            6.5.1    Market Estimates & Forecast, 2017-2023

      6.6    Cannabinoids

            6.6.1    Market Estimates & Forecast, 2017-2023

6.7    Others

            6.7.1    Market Estimates & Forecast, 2017-2023

7.    Global Nausea Medicine Market, by Mode of Administration

     7.1    Introduction

      7.2    IV

            7.2.1    Market Estimates & Forecast, 2017-2023

      7.3    Tablets

            7.3.1    Market Estimates & Forecast, 2017-2023

      7.4    Others

            7.4.1    Market Estimates & Forecast, 2017-2023

8.    Global Nausea Medicine Market, by Indication

     8.1    Introduction

      8.2    gastroesophageal reflux disease (GERD)

            8.2.1    Market Estimates & Forecast, 2017-2023

      8.3    Viral gastroenteritis

            8.3.1    Market Estimates & Forecast, 2017-2023

      8.4    Motion sickness and seasickness

            8.4.1    Market Estimates & Forecast, 2017-2023

      8.5    Medication

            8.5.1    Market Estimates & Forecast, 2017-2023

      8.6    Chemotherapy

            8.6.1    Market Estimates & Forecast, 2017-2023

      8.7    Others

            8.7.1    Market Estimates & Forecast, 2017-2023

9.    Global Nausea Medicine Market, by End User

      9.1    Introduction

      9.2    Hospital 

            9.2.1    Market Estimates & Forecast, 2017-2023

      9.3    Clinics

            9.3.1    Market Estimates & Forecast, 2017-2023

      9.4    Pharmaceutical Companies

            9.4.1    Market Estimates & Forecast, 2017-2023

      9.5    Others

            9.5.1    Market Estimates & Forecast, 2017-2023

10.    Global Nausea Medicine Market, by Region

      10.1    Introduction

      10.2    Americas

            10.2.1    North America

                10.2.1.1    US

                10.2.1.1    Canada

            10.2.2    South America

      10.3    Europe

            10.3.1    Western Europe

                10.3.1.1    Germany

                10.3.1.2    France

                10.3.1.3    UK

                10.3.1.4    Italy

                10.3.1.5    Spain

                10.3.1.6    Rest of Western Europe

            10.3.2    Eastern Europe

      10.4    Asia Pacific

            10.4.1    Japan

            10.4.2    China

            10.4.3    India

            10.4.4    Australia

            10.4.5    Republic of Korea

            10.4.6    Rest of Asia Pacific

      10.5    The Middle East & Africa

            10.5.1    United Arab Emirates

            10.5.2     Saudi Arabia

            10.5.3    Oman

            10.5.4    Kuwait

            10.5.5    Qatar

            10.5.6    Rest of the Middle East & Africa

11    Company Landscape    

      11.1    Introduction    

      11.2    Market Share Analysis    

      11.3    Key Development & Strategies    

            11.3.1    Key Developments    

12    Company Profiles    

      12.1    Merck & Co., Inc.    

            12.1.1    Company Overview    

            12.1.2    Product Overview    

            12.1.3    Financials    

            12.1.4    SWOT Analysis    

      12.2    Sanofi    

            12.2.1    Company Overview    

            12.2.2    Product Overview    

            12.2.3    Financial Overview    

            12.2.4    Key Developments    

            12.2.5    SWOT Analysis    

      12.3    TESARO, Inc.    

            12.3.1    Company Overview    

            12.3.2    Product Overview    

            12.3.3    Financial Overview

            12.3.4    Key Development    

            12.3.5    SWOT Analysis    

      12.4    F. Hoffmann-La Roche Ltd 

            12.4.1    Company Overview    

            12.4.2    Product/Business Segment Overview    

            12.4.3    Financial Overview    

            12.4.4    Key Development    

            12.4.5    SWOT Analysis    

      12.5    Pfizer

            12.5.1    Company Overview    

            12.5.2    Product Overview    

            12.5.3    Financial overview    

            12.5.4    Key Developments    

      12.6    GlaxoSmithKline

            12.6.1    Company Overview    

            12.6.2    Product Overview    

            12.6.3    Financial Overview    

            12.6.4    Key Developments    

      12.7    ANI Pharmaceuticals, Inc. 

            12.7.1    Overview    

            12.7.2    Product Overview    

            12.7.3    Financials    

            12.7.4    Key Developments    

            12.7.5    SWOT Analysis    

    12.8    Others

13    MRFR Conclusion    

      13.1    Key Findings    

            13.1.1    From CEO’s View Point    

            13.1.2    Unmet Needs of the Market    

      13.2    Key Companies to Watch    

      13.3    Prediction of Pharmaceutical Industry

14    Appendix

LIST OF TABLES

Table 1        Nausea Medicine Industry Synopsis, 2017-2023

Table 2        Global Nausea Medicine Market Estimates and Forecast, 2017-2023, (USD Million)

Table 3        Global Nausea Medicine Market by Region, 2017-2023, (USD Million)

Table 4        Global Nausea Medicine Market by Types, 2017-2023, (USD Million)

Table 5        Global Nausea Medicine Market by Mode of Administration, 2017-2023, (USD Million)

Table 6        Global Nausea Medicine Market by Indication, 2017-2023, (USD Million)

Table 7        Global Nausea Medicine Market by End Users, 2017-2023, (USD Million)

Table 8        North America Nausea Medicine Market by Types, 2017-2023, (USD Million)

Table 9        North America Nausea Medicine Market by Mode of Administration, 2017-2023, (USD Million)

Table 10    North America Nausea Medicine Market by Indication, 2017-2023, (USD Million)

Table 11    North America Nausea Medicine Market by End Users, 2017-2023, (USD Million)

Table 12    US Nausea Medicine Market by Types, 2017-2023, (USD Million)

Table 13    US Nausea Medicine Market by Mode of Administration, 2017-2023, (USD Million)

Table 14    US Nausea Medicine Market by Indication, 2017-2023, (USD Million)

Table 15    US Nausea Medicine Market by End Users, 2017-2023, (USD Million)

Table 16    Canada Nausea Medicine Market by Types, 2017-2023, (USD Million)

Table 17    Canada Nausea Medicine Market by Mode of Administration, 2017-2023, (USD Million)

Table 18    Canada Nausea Medicine Market by Indication, 2017-2023, (USD Million)

Table 19    Canada Nausea Medicine Market by End Users, 2017-2023, (USD Million)

Table 20    South America Nausea Medicine Market by Types, 2017-2023, (USD Million)

Table 21    South America Nausea Medicine Market by Mode of Administration, 2017-2023, (USD Million)

Table 22    South America Nausea Medicine Market by Indication, 2017-2023, (USD Million)

Table 23    South America Nausea Medicine Market by End Users, 2017-2023, (USD Million)

Table 24    Europe Nausea Medicine Market by Types, 2017-2023, (USD Million)

Table 25    Europe Nausea Medicine Market by Mode of Administration, 2017-2023, (USD Million)

Table 26    Europe Nausea Medicine Market by Indication, 2017-2023, (USD Million)

Table 27    Europe Nausea Medicine Market by End Users, 2017-2023, (USD Million)

Table 28    Western Europe Nausea Medicine Market by Types, 2017-2023, (USD Million)

Table 29    Western Europe Nausea Medicine Market by Mode of Administration, 2017-2023, (USD Million)

Table 30    Western Europe Nausea Medicine Market by Indication, 2017-2023, (USD Million)

Table 31    Western Europe Nausea Medicine Market by End Users, 2017-2023, (USD Million)

Table 32    Eastern Europe Nausea Medicine Market by Types, 2017-2023, (USD Million)

Table 33    Eastern Europe Nausea Medicine Market by Mode of Administration, 2017-2023, (USD Million)

Table 34    Eastern Europe Nausea Medicine Market by Indication, 2017-2023, (USD Million)

Table 35    Eastern Europe Nausea Medicine Market by End Users, 2017-2023, (USD Million)

Table 36    Asia Pacific Nausea Medicine Market by Types, 2017-2023, (USD Million)

Table 37    Asia Pacific Nausea Medicine Market by Mode of Administration, 2017-2023, (USD Million)

Table 38    Asia Pacific Nausea Medicine Market by Indication, 2017-2023, (USD Million)

Table 39    Asia Pacific Nausea Medicine Market by End Users, 2017-2023, (USD Million)

Table 40    Middle East & Africa Nausea Medicine Market by Types, 2017-2023, (USD Million)

Table 41    Middle East & Africa Nausea Medicine Market by Mode of Administration, 2017-2023, (USD Million)

Table 42    Middle East & Africa Nausea Medicine Market by Indication, 2017-2023, (USD Million)

Table 43    Middle East & Africa Nausea Medicine Market by End Users, 2017-2023, (USD Million)



LIST OF FIGURES

Figure 1    Research Process

Figure 2    Segmentation for Global Nausea Medicine Market

Figure 3    Segmentation Market Dynamics for Nausea Medicine Market

Figure 4    Global Nausea Medicine Market Share, by Mode of Administration 2016

Figure 5    Global Nausea Medicine Market Share, by Indication 2016

Figure 6    Global Nausea Medicine Market Share, by End Users, 2016

Figure 7    Global Nausea Medicine Market Share, by Region, 2016

Figure 8    North America Nausea Medicine Market Share, by Country, 2016

Figure 9    Europe Nausea Medicine Market Share, by Country, 2016

Figure 10    Asia Pacific Nausea Medicine Market Share, by Country, 2016

Figure 11    Middle East & Africa Nausea Medicine Market Share, by Country, 2016

Figure 12    Global Nausea Medicine Market: Company Share Analysis, 2016 (%)

Figure 13    Merck & Co., Inc.: Key Financials

Figure 14    Merck & Co., Inc.: Segmental Revenue

Figure 16    Merck & Co., Inc.: Geographical Revenue

Figure 17    Sanofi: Key Financials

Figure 18    Sanofi: Segmental Revenue

Figure 19    Sanofi: Geographical Revenue

Figure 20    TESARO, Inc.: Key Financials

Figure 21    TESARO, Inc.: Segmental Revenue

Figure 22    TESARO, Inc.: Geographical Revenue

Figure 23    F. Hoffmann-La Roche Ltd: Key Financials

Figure 24    F. Hoffmann-La Roche Ltd: Segmental Revenue

Figure 25    F. Hoffmann-La Roche Ltd: Geographical Revenue

Figure 26    GlaxoSmithKline: Key Financials

Figure 27    GlaxoSmithKline: Segmental Revenue

Figure 28    GlaxoSmithKline: Geographical Revenue

Figure 29    Pfizer: Key Financials

Figure 30    Pfizer: Segmental Revenue

Figure 31    Pfizer: Geographical Revenue

Figure 32    Pfizer Inc: Key Financials

Figure 33    Pfizer Inc: Segmental Revenue

Figure 34    Pfizer Inc: Geographical Revenue